Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Protara Therapeutics

NASDAQ TARA
$3.00 0.02 0.67%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 16 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

34.26M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
-4.34M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
-
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
11.42M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
59.99 %

Upcoming events Protara Therapeutics

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Protara Therapeutics

Stock analysis Protara Therapeutics

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.81 27.22
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
0.50 3.54
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
0.10 9.69
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.85 -0.16
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-72.72 13.82

Price change Protara Therapeutics per year

6.18$ 27.51$
Min Max

Summary analysis Protara Therapeutics

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Protara Therapeutics

Revenue and net income Protara Therapeutics

All parameters

Stock news Protara Therapeutics

All news
30 January 2023 в 16:40

Protara Therapeutics Names Patrick Fabbio as CFO

30 January 2023 в 16:35

Protara Therapeutics Names Patrick Fabbio as CFO

12 October 2021 в 14:35

Protara Therapeutics: FDA Clears IND Application for TARA-002 in Bladder Cancer

12 October 2021 в 14:30

Protara Therapeutics: FDA Clears IND Application for TARA-002 in Bladder Cancer

About company Protara Therapeutics

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.
Address:
345 Park Avenue South, New York, NY, United States, 10010
Company name: Protara Therapeutics
Issuer ticker: TARA
ISIN: US74365U1079
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2014-10-22
Sector: Healthcare
Industry: Biotechnology
Site: https://www.protaratx.com

On which stock exchange are Protara Therapeutics (TARA) stocks traded?

Protara Therapeutics (TARA) stocks are traded on NASDAQ.

What is the ticker of Protara Therapeutics stocks (TARA)?

The stock ticker of Protara Therapeutics’s stocks or in other words, the code is TARA. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Protara Therapeutics (TARA) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Protara Therapeutics (TARA) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Protara Therapeutics (TARA) stocks traded?

Protara Therapeutics (TARA) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Protara Therapeutics (TARA) stocks today?

The current price of Protara Therapeutics stocks on 11.05.2024 is 3 dollars. per share.

What is the dynamics of Protara Therapeutics (TARA) stocks from the beginning of the year?

Protara Therapeutics (TARA) quotes have increased by 42.86% from the beginning of the year up to 3 dollars. per 1 stocks.

How much did Protara Therapeutics (TARA) stocks increase in мае 2024?

This month Protara Therapeutics (TARA) quotes have increased by 2.39% to 3 dollars. per share.

How much are Protara Therapeutics (TARA) stocks worth?

Today, on October, 11.05.2024 Protara Therapeutics’s (TARA) stocks cost 3 dollars..

What is the market capitalization of Protara Therapeutics (TARA)?

Capitalization is the market value of Protara Therapeutics (TARA) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 11.05.2024, the market capitalization of Protara Therapeutics (TARA) is estimated at about 34262844 dollars.